Top Stories
-
Columbia expert Dr. Fatemeh Momen-Heravi shares facts about HPV-related cancer risk factors and prevention.
-
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Topic
-
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
Topic
-
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Topic
Latest News
- October 27, 2014
A CUMC study found that the use of generic aromatase inhibitors, which cost considerably less than their brand-name counterparts, increased treatment adherence by 50 percent.
Topic
- October 9, 2014
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
Topic
- August 27, 2014
The Herbert Irving Comprehensive Cancer Center is one of only two NCI-designated Comprehensive Cancer Centers in New York City and one of only three in New York State.
Topic
- August 26, 2014
Columbia surgeons and radiation oncologists deliver precise radiotherapy immediately following cancer tumor removal.
Topic
- August 20, 2014
Research from Columbia shows that nerves play a critical role in stomach cancer growth and blocking nerve signals using surgery or Botox® could provide an effective therapy for the disease.
- July 30, 2014
Columbia experts worked together to offer an innovative option to a pregnant woman needing radiation therapy for a fast-growing brain tumor.
Topic
- July 22, 2014
Patients considering morcellation should be counseled about the prevalence of cancerous and precancerous conditions prior to undergoing the procedure.
Topic
- July 11, 2014
In preclinical tests, a two-drug combination that blocks cancer’s escape route shows promise against MPNST, an aggressive nerve tumor.
Topic
- July 9, 2014
The new 2014 Irving Scholars are Siddhartha Mukherjee, Carolyn Rodriguez, Bret Rutherford, and Anne-Catrin Uhlemann.
Topic
- July 3, 2014
New technology allows scientists to dive into the inner world of cells in everything from cancers to mummies. Learn more at lab’s open house on July 10.
Topic
